Hao Ying, Ji Tong-Tong, Gu Shu-Yi, Zhang Shan, Gu Yao-Hua, Guo Xia, Zeng Li, Gang Fang-Yin, Xiong Jun, Feng Yu-Qi, Xie Neng-Bin, Yuan Bi-Feng
College of Chemistry and Molecular Sciences, Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan University Wuhan 430071 China
Department of Occupational and Environmental Health, School of Public Health, Research Center of Public Health, Renmin Hospital of Wuhan University, Wuhan University Wuhan 430071 China
Chem Sci. 2025 Apr 15. doi: 10.1039/d5sc00861a.
Protein evolution has emerged as a crucial tool for generating proteins with novel characteristics. A key step in protein evolution is the mutagenesis of protein-coding DNA. Error-prone PCR (epPCR) is a frequently used technique, but its low mutation efficiency often requires multiple rounds of mutagenesis, which can be time-consuming. To address this, we developed a novel DNA mutagenesis strategy termed deaminase-driven random mutation (DRM). DRM utilizes the engineered cytidine deaminase A3A-RL and the engineered adenosine deaminase ABE8e to introduce a broad spectrum of mutations, including C-to-T, G-to-A, A-to-G, and T-to-C, in both the protein-coding strand and the complementary strand. This approach enables the generation of a multitude of DNA mutation types within a single round of mutagenesis, resulting in a higher DNA mutagenic capability than epPCR. The results show that the DRM strategy exhibits a 14.6-fold higher DNA mutation frequency and produces a 27.7-fold greater diversity of mutation types compared to epPCR, enabling a more comprehensive exploration of the genetic landscape. This enhanced mutagenic capability increases the chances of discovering novel and useful mutants. With its ability to produce high-quality DNA products and the superior protein mutant generation capacity, DRM is an attractive tool for researchers seeking to engineer new proteins or improve existing ones.
蛋白质进化已成为生成具有新特性蛋白质的关键工具。蛋白质进化的一个关键步骤是蛋白质编码DNA的诱变。易错PCR(epPCR)是一种常用技术,但其低突变效率通常需要多轮诱变,这可能很耗时。为了解决这个问题,我们开发了一种名为脱氨酶驱动随机突变(DRM)的新型DNA诱变策略。DRM利用工程化的胞嘧啶脱氨酶A3A-RL和工程化的腺苷脱氨酶ABE8e在蛋白质编码链和互补链中引入广泛的突变,包括C到T、G到A、A到G和T到C。这种方法能够在一轮诱变中产生多种DNA突变类型,从而比epPCR具有更高的DNA诱变能力。结果表明,与epPCR相比,DRM策略的DNA突变频率高14.6倍,产生的突变类型多样性高27.7倍,能够更全面地探索遗传景观。这种增强的诱变能力增加了发现新的有用突变体的机会。凭借其产生高质量DNA产物的能力和卓越的蛋白质突变体生成能力,DRM对于寻求设计新蛋白质或改进现有蛋白质的研究人员来说是一个有吸引力的工具。